Stay updated on Etokimab in Adult Peanut Allergy: Clinical Trial
Sign up to get notified when there's something new on the Etokimab in Adult Peanut Allergy: Clinical Trial page.

Latest updates to the Etokimab in Adult Peanut Allergy: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a revision note Revision: v3.4.2 and removed older government-status notices; no study data or content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH operating status (cc.nih.gov and opm.gov). Updated the revision to v3.4.1 and removed v3.4.0.SummaryDifference0.4%

- Check40 days agoChange DetectedUI updates include showing the glossary. Metadata changes update QC-related labels (Last Update Submitted that Met QC Criteria) and FEAR Act labeling, and the revision number to v3.4.0, removing the previous v3.3.4.SummaryDifference0.2%

- Check55 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a dedicated Locations section listing California and Washington, and removed the previous California Locations and Washington Locations labels.SummaryDifference0.3%

- Check104 days agoChange DetectedPublications section wording updated: the description now reads 'about the results of the study' instead of 'about the study results', and the revision labels are v3.3.2 (added) and v3.2.0 (deleted). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Etokimab in Adult Peanut Allergy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etokimab in Adult Peanut Allergy: Clinical Trial page.